- Home
- CGCT vs GEVO Comparison
CGCT vs GEVO Comparison
Compare CGCT & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGCT
- GEVO
- Stock Information
- Founded
- CGCT 2024
- GEVO 2005
- Country
- CGCT United States
- GEVO United States
- Employees
- CGCT N/A
- GEVO N/A
- Industry
- CGCT
- GEVO Major Chemicals
- Sector
- CGCT
- GEVO Industrials
- Exchange
- CGCT NYSE
- GEVO Nasdaq
- Market Cap
- CGCT 345.7M
- GEVO 354.6M
- IPO Year
- CGCT 2025
- GEVO 2011
- Fundamental
- Price
- CGCT $10.05
- GEVO $1.47
- Analyst Decision
- CGCT
- GEVO Buy
- Analyst Count
- CGCT 0
- GEVO 2
- Target Price
- CGCT N/A
- GEVO $7.58
- AVG Volume (30 Days)
- CGCT 14.9K
- GEVO 4.9M
- Earning Date
- CGCT 01-01-0001
- GEVO 08-11-2025
- Dividend Yield
- CGCT N/A
- GEVO N/A
- EPS Growth
- CGCT N/A
- GEVO N/A
- EPS
- CGCT N/A
- GEVO N/A
- Revenue
- CGCT N/A
- GEVO $42,034,000.00
- Revenue This Year
- CGCT N/A
- GEVO $1,022.79
- Revenue Next Year
- CGCT N/A
- GEVO $12.26
- P/E Ratio
- CGCT N/A
- GEVO N/A
- Revenue Growth
- CGCT N/A
- GEVO 145.38
- 52 Week Low
- CGCT $10.00
- GEVO $0.48
- 52 Week High
- CGCT $11.16
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- CGCT N/A
- GEVO 52.84
- Support Level
- CGCT N/A
- GEVO $1.43
- Resistance Level
- CGCT N/A
- GEVO $1.58
- Average True Range (ATR)
- CGCT 0.00
- GEVO 0.09
- MACD
- CGCT 0.00
- GEVO -0.01
- Stochastic Oscillator
- CGCT 0.00
- GEVO 36.36
About CGCT CARTESIAN GROWTH CORP III
Cartesian Growth Corp III is a blank check company.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.